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The genetic basis for autoimmunity in New Zealand mice has been investigated for 
two decades. These studies have suggested that several genes underlie the autoimmune 
process (1-10). The advent of new murine models of autoimmunity that display some 
of the traits of NZB mice while lacking others has led to a resurgence of interest in the 
genetic  basis  for autoimmunity  (11-14).  The  major question  is whether  there  is  a 
single fundamental defect that gives rise to autoimmunity. 
We have investigated this question by trying to determine whether the autoimmune' 
traits in NZB mice are linked to or dependent upon another trait for their appearance. 
We have previously shown (15)  by classical genetic analyses of F1 and backcrosses of 
NZB ×  DBA/2 mice that antibodies against T  cells and antibodies directed against 
single-stranded DNA (ssDNA)a were genetically determined traits not linked to each 
other. Moreover, they were expressed in a  gene dosage fashion. Other traits, splenic 
aneuploidy and splenomegaly, were inherited as recessive traits; they were found only 
in backcross mice  (16).  By analyzing several other crosses of NZB  mice with  non- 
autoimmune mice, we hoped to determine whether these were consistent findings. 
In addition  to classical genetic studies, we have also used a  powerful genetic tool, 
recombinant  inbred  (RI)  lines, to further analyze the inheritance  of autoimmunity 
(17-20).  RI lines were obtained by mating an NZB mouse with a  non-autoimmune 
mouse. The F2 mice were separately mated to initiate the RI lines and then brother- 
sister mated at each successive generation. Each RI line can have any combination of 
parental genes.  After several generations of inbreeding,  individual  RI lines become 
largely homozygous at most loci. Therefore, recessive genes are observed as easily as 
dominant  genes. Our studies indicate that multiple genes underlie NZB disease;  no 
single gene for autoimmunity was discovered. 
Materials and Methods 
Mice.  The progenitor strains that gave rise to the various RI lines were obtained from the 
Division  of Research Services, National Institutes of Health, Bethesda, Md. The RI lines were 
derived from pairs of (ALN ×  NZB)F2 or (inbred NIH Swiss [NFS] ×  NZB)F2 mice. Each RI 
line was then inbred by brother-sister mating for at least  14 generations. B lines are RI lines 
produced from (NZB ×  ALN) matings and C lines are produced from (NFS ×  NZB) matings. 
1 Abbreviations used in this paper: NTA, naturally occurring thymocytotoxic autoantibodies; RI, recombi- 
nant inbred; Sip, sex-limited serum protein; ssDNA, single-stranded DNA. 
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To date, we have studied 12 B lines and  15 C  lines. Individual mice from each RI line were 
then studied for various NZB traits. At least  10 males and  10 females from every line were 
analyzed. The measurements of various autoantihodies, splenomegaly, aneuploidy, and abnor- 
mal cell cycle kinetics were performed on  mice at  1 yr of age. A  line was considered to be 
positive for a trait if at least 60% of the mice from that line manifested the trait. A few RI lines 
were significantly different from both NZB parents and normal parents. 
In addition to RI mice, ,~arious  other mice were studied. NZB/N and DBA/2 mice were 
crossed in our laboratory to produce F1 progeny. F1 hybrids were backcrossed to both parental 
strains. Additional crosses involved (NZB ×  C3H/HeN)  and (NZB ×  BALB/c); both of these 
F~ hybrids were backcrossed to their respective parents. 
Sera.  Mice were bled by retro-orbital sinus puncture under light ether anesthesia. The blood 
was allowed to clot for 2 h at room temperature; the sera were removed and stored at -20°C 
until used. 
Naturally Occurring Thymocytotoxic Autoantibodies (NTA).  NTA was measured by a chromium 
release assay using selected rabbit complement as previously described (15). A positive test was 
>50% cytotoxicity at a serum dilution of 1:4. 
Antibodies Directed against ssDNA.  Spontaneously occurring antibodies reactive with ssDNA 
were measured by the Farr technique as previously described (15).  Positive sera had >25% 
binding. 
Antibodies Directed against E~throcytes.  Antibodies against erythrocytes were measured by a 
direct Coombs test (21). A test was considered strongly positive when it had a titer of >6 wells 
(1:640 final dilution of the anti-Ig reagent). 
Serum IgM Concentration.  IgM levels were determined by radial immunodiffusion with Meloy 
plates (Meloy Laboratories Inc., Springfield, Va.). Known positive and negative controls were 
included on each plate. An IgM concentration was considered abnormal if it was >0.6 mg/ml. 
Splenomegaly.  Immediately after a mouse was killed by cervical dislocation, the spleen was 
removed and weighed. Spleen weights >250 mg were considered abnormal. 
Aneuploidy.  Mitotic  spleen  cells  were  analyzed  for  chromosome  number  as  previously 
described  (16).  If >10%  of the  spleen  cells had  at  least  42  chromosomes,  the  mouse  was 
considered abnormal. 
Cell Cycle.  Spleen cells were stained with propidium iodide (22) and analyzed on a TPS I 
cell sorter (Coulter Electronics, Inc., Hialeah, Fla.) for the amount of fluorescence due to DNA 
content. Percentages of cells in G1, S, and G2 +  M  phases of the cell cycle were determined 
using a  mathematical analogram.  Percentages of cells >10%  in S  or >2%  in Go +  M  were 
considered abnormal. 
Sex-limited Serum Protein (Slp).  Sip was measured by radial immunodiffusion as previously 
described (23). Abnormal female production of Slp was >0.5 U/ml. 
Results 
Prevalence of Autoimmune  Traits in RI Lines.  Table I shows the prevalence of various 
traits in the RI lines derived from NZB matings. Parent  B, which gave rise to the B 
lines, displayed none of the abnormal traits found in NZB mice. However, parent C, 
which is an inbred NFS, did produce high-titered anti-T cell antibodies. These anti- 
T  cell autoantibodies were not associated with excessive IgM production, whereas the 
two traits are associated in NZB mice. Anti-T cell antibodies appear to be regulated 
by separate genes in the two strains because several NFS X NZB lines did not produce 
anti-T cell antibodies. In  NZB  mice, the control is by a  single locus  (15;  and  data 
from the B  lines). 
No  RI  line displayed all of the  traits  of the  NZB  parent.  Lines C-10  and  C-11 
displayed  six  of  the  seven  NZB  traits  studied.  Line  B-8  displayed  none  of  the 
autoimmune  traits of NZB  and was  therefore similar to the non-autoimmune  ALN 
parent,  with  the  exception  of abnormal  female  production  of Sip.  The  abnormal 
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TABLE  I 
Prevalence of Various Traits Characteristic of NZB Mice in RI Lines* 
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Anti- 
Anti-  erythro-  Sip  Spleno-  Hyperdi-  1' Cells in 
RI line  NTA*  ~" IgM  ssDNA  cytes  megaly  ploidy  S phase 
NZB  +  (90)  +  (90)  +  (80)  +  (100)  +  (100)  +  (90)  +  (70)  +  (90) 
Parent B  -  (10)  -- (0)  -- (10)  -- (0)  -- (0)  -- (0)  -- (0)  -- (0) 
Parent C  +  (100)  -  (0)  -  (0)  -  (0)  -  (0)  -  (10)  -  (0)  -  (10) 
B-1§  -  (13)  +  (80)  -  (9)  -  (0)  -  (0)  -  (0)  -  (0)  -  (0) 
B-2  +  (100)  -  (12)  +  (75)  -  (0)  +  (100)  -  (0)  -  (0)  -  (0) 
B-3  +  (67)  +  (67)  +  (80)  -  (0)  +  (100)  -  (0)  -  (0)  -  (0) 
B-4  -  ((3)  --  (0)  +  (100)  -  (0)  +  (100)  -  (0)  -  (0)  -  (0) 
B-5  +  (67)  +  (100)  -  (17)  -  (0)  +  (100)  -- (0)  -- (0)  -- (0) 
B-6  NDll  +  (73)  +  (83)  ND  -  (0)  +  (100)  +  (66)  ND 
B-7  +  (86)  +  (60)  +  (100)  -  (0)  +  (100)  +  (100)  -  (0)  ND 
B-8  -  (0)  -  (0)  -  (0)  -  (0)  +  (100)  -  (0)  -  CO)  -  Co) 
B-9  -  (0)  -  (0)  +  (83)  ND  -  (0)  -  (0)  -  (0)  +  (100) 
B-10  -  (0)  -  (0)  +  (83)  ND  +  (100)  -  (0)  -  (0)  -  (0) 
B-11  -  (0)  -  (20)  -  (0)  ND  +  (100)  +  (100)  +  (60)  ND 
B-12  +  (100)  +  (100)  +  (100)  ND  +  (100)  ND  ND  ND 
B-13  -  (0)  -  (0)  +  (100)  -  (0)  +  (100)  -  (0)  -  (0)  -  (0) 
B-14  --  (25)  +  (60)  --  (0)  --  (0)  -  (0)  --  (0)  --  (0)  ND 
B-15  +  (82)  +  (86)  -  (13)  -  (0)  -  (0)  -  (0)  -  (0)  -  Co) 
c-1  +  (75)  +  (75)  +  (100)  -  (0)  +  (100)  -  (0)  +  (71)  +  (too) 
c-2  -  (27)  -  (31)  +  (lOO)  +  (60)  -  (0)  +  (100)  +  (8o)  -  (0) 
c-3  -  (14)  -  (0)  +  (90)  +  (75)  -  (0)  -  (0)  -  (0)  -  (0) 
c-4  +  0o)  +  (80)  -  (21)  -  (o)  -  (0)  +  (75)  +  (100)  -  (o) 
C-5  +  (83)  -  (0)  -  (31)  -  (17)  +  (100)  +  (100)  +  (100)  -  (0) 
C-6  -  ({9)  -  (0)  -  (10)  -  (0)  +  (75)  -  C  0)  -  (0)  -  (0) 
c-7  +  (63)  +  (100)  -  (35)  -  (15)  -  (0)  -  (0)  +  (60)  +  (6o) 
C-8  -  (25)  -  (0)  -  (0)  -  (0)  ND  +  (100)  +  (66)  +  (100) 
C-9  +  (100)  +  (100)  +  (100)  -- (0)  ND  +  (100)  -- ((3)  +  (100) 
C-10  +  (71)  +  (71)  +  (100)  +  (67)  ND  +  (100)  +  (100)  -  (0) 
C-11  +  (100)  +  (100)  +  (100)  -  (0)  ND  +  (100)  +  (100)  +  (100) 
C-12  +  (83)  +  (100)  +  (100)  -  (0)  ND  +  (100)  +  (100)  -  ((3) 
~' indicates increase over normal. 
* Only female data are presented because there were sex differences in some lines. The percentage of 10-30 
mice examined expressing the trait  in an individual line, or parent strain, is shown in parentheses. 
:]: Plus sign indicates presence of trait;  minus sign indicates lack of trait. 
§ B-t, B-2, B-3, etc., are each separate RI lines. There are  12 different B lines and  15 different C  lines. 
U Not determined. 
abnormalities  in  the  present  study  and  in  separate  backcross  experiments  (data  not 
shown). 
A  summary  of the  prevalence  of NZB  traits  in the  two  different  RI  lines  is presented 
in  Table  II.  NTA,  anti-ssDNA,  and  increased  IgM  each  occurred  in  -50%  of  the 
lines,  which  suggests  control  by  single  genes.  The  results  in  B  lines  and  C  lines  were 
similar.  However,  B  lines  differed  significantly  from  C  lines  in  the  incidence  of 
splenomegaly  and  hyperdiploidy.  In  addition,  none  of  the  B  lines  displayed  anti- 
erythrocyte  autoantibodies,  whereas  25%  of  the  C  lines  were  positive  for  anti-eryth- 
rocyte  autoantibodies  (although  this  difference  is  not  statistically  significant,  we 
believe  that  it  might  be  biologically  important). 
Based  on  the  incidence  of  autoimmune  traits  in  RI  lines,  various  genetic  models 1190  GENETIC  STUDIES IN NZB  MICE 
TABLE II 
Summary of RI Lines 
RI lines  NTA  T IgM  Anti-ssDNA  Anti-erythro-  Females with  Hyper-  ]" Cells in S 
cytes  Sip  Sp|enomegaly  diploidy  phase 
B lines  6/14'  (43)  8/15 (53)  9/15 (60)  0/10 (0)  10/15  (67)  3/145  (21)  2/14:~ (14)  1/10 (10) 
C lines  8/12  (67)  7/12 (58)  7/12  (50)  3/12 (25)  3/7  (43)  8/12~ (67)  9/12:~ (75)  5/12 (42) 
All lines  14/26  (54)  15/27  (56)  16/27 (59)  3/22 (14)  13/22  (59)  11/26  (42)  11/26  (42)  6/22 (27) 
* Fractions  represent  number over total.  Percentages  are in parentheses. 
:~ B lines significantly  different  from C lines by Fisher exact test  (two-tailed),  P <  0.05. 
TABLE III 
Expected Outcome of Different Modes of Inheritance in RI Lines 
Type 
Frc- 
NZB genotype  Genotype of  Genotypes of  quenCYof 
required for  normal parent  possible RI lines  expres- 
phenotype (+)  without phe-  and phenotype  sion of 
notype (-)  (+ or -)  RI 
lines 
I One gene 
II Two genes 
III Three genes 
IV Two genes; normal parent with one 
gene but lacking expression of trait 
V Three genes; normal parent with one 
gene but lacking expression of trait 
VI One trait; controlled  in individual 
strains  by different  single genes and 
both parents expressing trait 
VII Three genes; normal  parent with 
two  genes but  lacking  expression of 
trait 
% 
AA(+)  aa(-)  AA(+)  50 
aa(-) 
AABB(+)  aabb(-)  AAbb(-)  25 
AABB(+) 
aabb(-) 
aaBB(-) 
AABBCC(+)  aabbcc(-)  AABBCC(+)  12.5 
AAbbcc(-) 
aaBBce(-) 
aaBBCC(-) 
aabbCC(-) 
AABBcc(-) 
aabbcc(-) 
AAbbCC(-) 
AABB(+)  AAbb(-)  AABB(+)  50 
AAbb(-) 
AABBCC(+)  AAbbcc(-)  AABBCC(+)  25 
AAbbec(-) 
AABBcc(-) 
AAbbCC(-) 
AAbb(+)  aaBB(+)  AAbb(+)  75 
AABB(+) 
aaBB(+) 
aabb(-) 
AABBCC(+)  AABBcc(-)  AABBCC(+)  50 
AABBcc(-  1) 
were analyzed for closeness of fit to the observed data for both B  and C  RI lines. In 
Table III, the expected incidence of traits in RI lines is shown  for various modes of 
inheritance. As inbreeding proceeds, heterozygotes are diminished, and full homozy- 
gosity  at  all  loci  is  approached.  As  a  result,  dominant  and  recessive  genes  are 
detectable  with  equal  frequency.  Theoretically,  each  RI  line  represents  multiple 
replicates of an  individual F2 recombinant  mouse.  The  presence of multiple copies RAVE12HE, NOVOTNY,  HANSEN,  TJIO,  AND STEINBERG  1191 
diminishes problems of penetrance  in  genetic analysis. For instance,  in  NZB  mice, 
NTA  are  expressed  with  a  0.91  frequency  by  standard  genetic  analysis of F1  and 
backcross  mice  (15).  This  lack  of  complete  penetrance  complicates  F2  analyses. 
However, in RI line analysis, all but one mouse in an RI line may display anti-T cell 
antibodies, and this line can easily be identified as positive for the presence of NTA. 
This advantage is even more obvious when penetrance is only in the 0.7-0.8 frequency 
range, as is the case for aneuploidy. 
In Table IV, the most likely genetic model that was shown in Table III is assigned 
to each of the traits studied in the RI lines. Genetic mechanisms for the traits studied 
in the RI lines were assigned on the basis of (a) genetic models already determined on 
the  basis of F1 and  backcross studies  (15);  (b)  prevalence of a  trait  in  B  lines and 
linkage with other traits; and (c) comparison of the prevalence of the traits in C  lines 
TABLE  IV 
Most Probable Type of Inheritance of Traits in RI Lines Based on the Models Shown in Table III 
Anti-  Spleno  Hy-  1" cells 
RI lines  NTA  1'  Anti-  IgM  ssDNA  eryth-  Sip  me-  perdi-  in S 
rocytes  galy  ploidy  phase 
B lines  I*  I  I  III  I  II  II  III 
12 lines  VI  I  I  V  I  IV  IV  VII 
Minimum 
number of 
required 
genes 
Minimum 
number of 
genes for 
NZB phe- 
notype 
1  1  1  3  1  2  2  3 
1  +  0*  +  1  +  1§  +  1  +  111  4-  0¶  -4- 
=6 
* Roman numerals stand for models shown in Table III. 
~: Linked to NTA. 
§ The other two could be (i) suppressor gene and (ii) either of the previous two genes. 
II One could be one of the previous genes. 
¶ Could be any of the previous genes. 
** The other two genes could be any of the previous genes. 
TABLE  V 
Analysis of Linkage of Autoimmune Traits in RI Lines 
Hyperdiploidy (+)  Hyperdiploidy (-) 
Splenomegaly (+)  9  2 
Splenomegaly (-)  2  13" 
High IgM(+)  High IgM (-) 
NTA (+)  12  2 
NTA (-)  2  10" 
The appearance of NTA is linked to the presence of hypergammaglobuli- 
nemia M, and the presence of splenic hyperdiploidy  is linked to the presence 
of an enlarged spleen. No other associations among the various traits studied 
were found. 
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with that in B lines. Among the B lines, NTA and anti-ssDNA autoantibodies appear 
to be under the control of separate single genes. C  lines confirm these findings. 
The incidence of splenomegaly in B lines is 3/14.  If two genes were involved, the 
expected incidence would be 3.5/14.  This is close to the observed value. In C  lines, 
the incidence is much higher, suggesting that the normal NFS parent, which does not 
display splenomegaly, has one of the two genes that leads to an enlarged spleen. 
The number of RI lines in which the females produce Sip is similar to the number 
of lines that would be expected to have abnormal female Sip production if the trait 
were controlled by a single gene. A previous report with a limited number of RI lines 
has indicated that abnormal female production of Sip was controlled by one or two 
genes (24). In the RI lines, the presence of female Sip was not strongly associated with 
any of the autoimmune traits studied. 
Association of Autoimmune  Traits in RI Lines.  One of the uses of RI lines is the location 
of genes  on  particular  chromosomes through  linkage  analysis with  known  genetic 
markers. Additional  studies will be required  to determine the location of particular 
genes.  Our  initial  investigations  have  been  confined  to  the  determination  of the 
expression of autoimmune traits in RI lines and their linkage. If two traits segregated 
independently, the distribution should be random. On the other hand, if the two loci 
are linked, the frequency of recombinant types, which are positive for one trait and 
negative for the other,  should  be significantly  lower.  The observed distribution  for 
splenomegaly and  hyperdiploidy  varies significantly from that  expected  if the  two 
traits  were  not  linked  (Table  V).  Therefore,  splenomegaly  and  the  presence  of 
chromosomal hyperdiploidy appear to be linked.  This might occur if at least one of 
the genes for splenomegaly also is one of the genes for hyperdiploidy. Alternatively, 
one or  two  genes  for the  two  traits  might  be closely linked,  but  not  identical.  In 
addition, NTA was also associated with increased IgM levels (Table V). These traits 
may also be closely linked, but not controlled by the same gene, thereby accounting 
for the four divergent lines.  Alternatively, the same major gene may code for both, 
but  minor genes could  account  for the  divergent  lines  [IgM  (+)  and  NTA  (-),  or 
TABLE  VI 
Distribution of Hyperdiploidy- and Splenomegaly-positive and -negative Mice 
for All Backcrosses 
Splenomegaly (+)  Splenomegaly  (-) 
Hyperdiploidy (+)  15  2 
Hyperdiploidy (-)  14  10" 
* P < 0.05, Fisher exact test (one-tailed). 
TAnLE VII 
Classical Genetic Analysis in Females of Anti-Erythrocyte Antibodies 
Cross  Positive for Anti-erythrocytes 
NZB  15/15"  (100) 
BALB/c  1  / 12  (8) 
(BALB/c X NZB)F~  1/12  (8) 
Fa × NZB  14/22  (64) 
BALB/c × Fx  1/14  (7) 
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NTA (+)  and IgM (-)]. No other associations among the various traits were found 
besides splenomegaly-hyperdiploidy and IgM-NTA. 
Comparison of Results Obtained with RI Lines with  Those Obtained by Classical Backcross 
Analysis.  To ascertain if the proposed genetic models for the inheritance of a trait in 
the RI mice is similar to that obtained by classical genetic analysis, the NZB strain 
was separately mated with non-autoimmune DBA/2, C3H/Hen, and BALB/c mice, 
and the F1 and backcross progeny were analyzed for the presence of hyperdiploidy 
and splenomegaly, two traits found to be linked in the RI lines. Both hyperdiploidy 
and splenomegaly were inherited  in a  recessive manner (data not shown).  Hyperdi- 
ploidy  was  controlled  by  at  least  one  recessive  gene  and  perhaps  one  or  more 
additional  genes,  one  of which  might  be  present  in  BALB/c  mice.  In  addition, 
hyperdiploidy and  splenomegaly were studied  for any association with each other. 
88% of the time hyperploidy was observed, splenomegaly was also present (Table VI). 
This is significantly different from what would be expected if no association between 
the two traits were present, and is similar to the results obtained in RI lines. 
In addition, FI and backcross animals from crosses of the NZB strain with the non- 
autoimmune strain  BALB/c were studied  for the presence of anti-erythrocyte anti- 
bodies (Table VII). The trait was inherited in a recessive manner and was controlled 
by at  least  one recessive gene and  any number of dominant  genes.  Analysis in  RI 
mice indicated that anti-erythrocyte antibodies are controlled by more than one gene. 
The combined results suggest that anti-erythrocyte antibodies are controlled by one 
recessive gene and one or two dominant genes. 
Discussion 
The use of RI lines,  in addition  to classical genetic studies,  has provided insight 
into the genetic basis for autoimmunity in NZB mice. This analysis has indicated that 
multiple genes (at least six) are responsible for the autoimmune traits of NZB mice. 
That  is,  these genes are present  in  NZB mice, but  not  in  several non-autoimmune 
strains studied. Anti-T cell antibodies and antibodies to ssDNA were each found to be 
inherited as single traits controlled by unlinked genes in RI mice. These conclusions 
have been  supported  by standard  genetic  analyses of Ft  and  backcross mice. The 
results are consistent with our previous report of a  single dominant  gene for ssDNA 
expression and  a  separate gene  for anti-T cell antibodies  (15).  Our  results are also 
consistent  with  the suggestions of others  (25)  that  different  traits of NZB  mice are 
unlinked. 
Studies  of  NZB  ×  NZC  crosses  suggested  that  a  single  dominant  gene  was 
responsible  for  anti-erythrocyte  autoantibody  production  (5).  Additional  analyses 
indicated  the involvement of a  dominant  gene and also a  recessive gene  (10)  or, as 
Burnet  and  Holmes  postulated  (1),  the  involvement  of at  least  three  genes.  Our 
studies, both in backcross mice and in RI mice, support the idea that at least two and 
possibly three  genes  (one of which  is recessive)  are responsible for anti-erythrocyte 
autoantibodies. 
Splenic B  cells of NZB mice spontaneously secreted many times more IgM than 
those of normal strains (26). This spontaneous hypersecretion of IgM is due to at least 
two  independently  segregating  mechanisms  (27).  One  was a  single  dominant  gene 
that  determined  the number of IgM-containing cells;  a  second  recessive gene con- 
trolled the amount of IgM secreted per cell. However, the amount of IgM spontane- 1194  GENETIC STUDIES IN NZB MICE 
ously secreted per cell was regulated  by the number of IgM-containing cells in the 
population  (27).  In  the  experiments  reported  herein,  IgM levels seem to be under 
single gene control, similar to the control of the number of IgM-containing cells (27). 
It is possible that other genes affect serum IgM levels, but the major genetic control 
appears to be a single gene. 
The  RI  analysis  and  the  classical  F~  and  backcross  analyses  actually  provide 
somewhat different and complementary information. The F1 studies show whether a 
trait is expressed in a  dominant fashion. If it is dominant, backcrosses to the parent 
not expressing the trait  (in this case, the non-NZB parent) will allow for an analysis 
of the number of dominant genes required for the trait. If the trait is not expressed in 
Fx mice, backcrosses to the parent expressing the trait  (in this case, NZB) will allow 
an assessment of the number of recessive genes necessary for expression of the trait. 
However, such an analysis will not give an estimate of the number of genes necessary 
for the trait  if there are both  recessive and  dominant  genes necessary for the trait. 
This difficulty is overcome in  the RI analysis.  In  RI mice, dominant  and recessive 
genes are expressed equally; therefore, the frequency of a given trait is determined by 
the number of genes necessary for its expression; that is, the number of genes in which 
the "normal" and "abnormal" parents differ with regard to expression of that trait. 
Thus, if 50% of the lines express a trait, the two parental strains differ with respect to 
only one gene; a  single gene from the abnormal parent is most likely responsible. A 
trait  that  depends  upon  the presence of two abnormal  genes would  lead  to a  25% 
frequency in the RI lines. The use of RI lines has many advantages over F2 analyses. 
One advantage is minimization of the problem of incomplete penetrance of a trait by 
virtue of multiple animals with the same genetic make-up. As a  result,  a  trait with 
only 70 or 75%  penetrance can easily be identified in an individual  RI line because 
several animals from the line are studied.  In contrast, incomplete penetrance of that 
degree completely mars F2 analyses. In our RI analysis, major genes determining a 
trait have been analyzed; however, minor genes that might influence the magnitude 
of the  expression  of a  trait  have,  for simplicity, not  been  considered.  It should  be 
recognized that each RI line in its own right represents an inbred line with various 
manifestations of autoimmunity. Further studies of individual RI lines might help to 
elucidate the contributions of minor genes to the expression of individual autoimmune 
traits. 
In  the  present  study,  we  benefitted  from the  availability of RI  lines  from NZB 
matings with more than one non-NZB parent. This allowed us to estimate the genetic 
contribution  to various traits of the non-NZB parent,  and, thereby, to assign  more 
correctly the contribution to the trait of genes unique to NZB mice. For example, B 
lines and C  lines differed significantly in the expression of splenomegaly and hyper- 
diploidy. If only C lines were studied, one would propose that splenomegaly might be 
controlled by one gene on the basis of a 67% frequency. However, the 21% frequency 
of splenomegaly in B lines points to two genes, with the C parent possessing one of the 
two genes necessary for expression of the  trait.  Studies  of additional  RI lines with 
other  non-NZB  parents will  allow gene assignments to be made with even greater 
confidence. 
Some of the  NZB  traits were found  to be linked  in  RI lines.  Splenomegaly was 
found to correlate with the presence of splenic hyperdiploidy. 82% of the RI lines that 
displayed  hyperdiploidy  also  had  splenomegaly.  A  similar  significant  association RAVECHE, NOVOTNY, HANSEN, TJIO, AND STEINBERG  1195 
(88%)  was found in classical backcross analyses. We have previously found (28)  that 
hyperdiploid spleen cells are derived from NZB bone marrow stem cells. We presume 
that  the  splenomegaly and  the  hyperdiploidy  have  related  cellular  bases,  thereby 
explaining their strong concordance. These abnormal B cells have been found to be 
limited to the Lyb-5  + subset (28, 29). The same may be true of the abnormal increase 
in cycling cells in the S phase of DNA synthesis. It is likely that rapidly replicating B 
cells contribute  to the enlarged spleen,  to hyperdiploidy, and  to the abnormal cell 
cycle observed in NZB mice. 
The present  study has helped  to resolve the question  of a  gene necessary for the 
expression  of generalized  autoimmunity  in  NZB  mice.  If such  an  "autoimmunity 
gene" existed, only half of the RI lines would be expected to possess this prerequisite 
gene, and only these lines could express autoimmune traits. Lines that did not receive 
the  autoimmunity  gene could  possess  genes  for individual  autoimmune  traits,  but 
could not express them in the absence of a  postulated  autoimmunity gene.  Because 
each RI line has a 50% chance of inheriting each NZB gene, the requirement for both 
a  gene for an individual  trait, and an autoimmunity gene for its expression, would 
mean that only 25% of the lines could express the trait. As many as 50% of the lines 
could express the trait if the gene for the trait and the autoimmunity gene were closely 
linked.  However, both anti-T cell antibodies and anti-ssDNA antibodies were found 
to be unlinked  and present in 50% of the RI lines. This observation argues strongly 
against  an  autoimmunity  gene  necessary  for the  expression  of autoimmune  traits. 
Rather,  it  appears  that  NZB  disease  is  based  upon  several  genes,  which,  in  the 
aggregate, allow the expression of the autoimmune syndrome of NZB mice. 
Summary 
The genetic basis for autoimmunity in NZB mice has been investigated through 
analysis of recombinant inbred lines produced by mating NZB mice with two different 
non-autoimmune strains.  Several genes  (at least six) were found to be necessary for 
the production of eight traits characteristic of the NZB mice that were studied.  No 
fundamental genetic defect (an "autoimmunity gene") was identified that could give 
rise to the various autoimmune traits studied. This study strongly suggests that NZB 
disease results from the actions of several separate genes that  together result  in the 
characteristic manifestations of autoimmunity. 
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